SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.87-0.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Turbo Lawyer who wrote (3882)9/24/1997 1:53:00 AM
From: tom jones   of 17367
 
Data safety monitoring board on meningococcemia.
If the result is to continue phase III, I think I will sell most of my shares if there is no other good news. I can't see what the difference is between about 65 and 130 results. Maybe someone can explain the math on this. Sure would like to see the phase I/II data on this. One person gave a talk on these results and Xoma said it was very favorable, but I have seen nothing. I know BPI works but the problem is getting it to work. No results from hemorrhagic trauma phase II either. Would like to hear other opinions on what may happen after the board's news.
Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext